- Home
- BNTX vs RL Comparison
BNTX vs RL Comparison
Compare BNTX & RL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | RL |
|---|---|---|
| Founded | 2008 | 1967 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 22.1B |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | BNTX | RL |
|---|---|---|
| Price | $96.21 | $356.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 14 |
| Target Price | $137.40 | ★ $357.43 |
| AVG Volume (30 Days) | ★ 1.1M | 679.1K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | N/A | ★ 28.75 |
| EPS | N/A | ★ 13.54 |
| Revenue | $3,698,814,972.00 | ★ $7,570,600,000.00 |
| Revenue This Year | N/A | $10.57 |
| Revenue Next Year | $9.49 | $4.87 |
| P/E Ratio | ★ N/A | $26.40 |
| Revenue Growth | 3.70 | ★ 12.32 |
| 52 Week Low | $81.20 | $176.61 |
| 52 Week High | $129.27 | $374.00 |
Technical Indicators
Market Signals| Indicator | BNTX | RL |
|---|---|---|
| Relative Strength Index (RSI) | 38.91 | 60.69 |
| Support Level | $94.00 | $320.60 |
| Resistance Level | $104.05 | $374.00 |
| Average True Range (ATR) | 3.41 | 10.35 |
| MACD | -0.46 | 2.95 |
| Stochastic Oscillator | 11.26 | 67.12 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About RL Ralph Lauren Corporation
Founded by designer Ralph Lauren (current executive chairman and chief creative officer) in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.